MICROBIO CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.8 TWD | -0.36% |
|
+3.72% | -17.23% |
| Sales 2022 | 1.72B 52.94M 0 | Sales 2023 | 1.59B 48.93M 0 | Capitalization | 28.29B 870M 0 |
|---|---|---|---|---|---|
| Net income 2022 | 211M 6.49M - | Net income 2023 | -1.18B -36.28M - | EV / Sales 2022 | 16.4 x |
| Net cash position 2022 | 3.59B 110M 0 | Net cash position 2023 | 3.02B 92.77M 0 | EV / Sales 2023 | 15.9 x |
| P/E ratio 2022 |
152
x | P/E ratio 2023 |
-23.9
x | Employees | - |
| Yield 2022 |
0.06% | Yield 2023 |
-
| Free-Float | 68.04% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -0.36% | ||
| 1 week | +3.72% | ||
| Current month | -6.49% | ||
| 1 month | -6.49% | ||
| 3 months | -12.28% | ||
| 6 months | -22.30% | ||
| Current year | -17.23% |
1 week
40.50
42.00
1 month
39.5547.25
Current year
39.5551.00
1 year
39.5561.70
3 years
39.1274.18
5 years
8.83120.91
10 years
8.83120.91
| Managers | Title | Age | Since |
|---|---|---|---|
Ming Lian Kuo
CEO | Chief Executive Officer | - | 20/21/20 |
Ying Chun Wang
DFI | Director of Finance/CFO | - | 01/15/01 |
Ke Hsiang Chou
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yuan Ho Lai
BRD | Director/Board Member | 84 | 06/03/06 |
Kao Chung Tsai
BRD | Director/Board Member | 62 | 29/06/29 |
Hsien Shou Kuo
CHM | Chairman | 82 | 20/21/20 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 117 M€ | -0.14% | - | |
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 7 M€ | +2.58% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/24/30 | 41.8 | -0.36% | 799,104 |
| 29/24/29 | 41.95 | +2.82% | 1,554,687 |
| 26/24/26 | 40.8 | +0.12% | 925,809 |
| 25/24/25 | 40.75 | -0.85% | 934,817 |
| 24/24/24 | 41.1 | -1.20% | 1,335,701 |
End-of-day quote Taipei Exchange, April 30, 2024
More quotes
Microbio Co., Ltd. is a Taiwan-based company primarily engaged in the research, development, manufacture, distribution and wholesales of healthcare food products and pharmaceuticals. The Company provides fermentation products, including Tien Chun Bao (TCB) oral solutions; herbal products, including LeeHerb series products, as well as organic foods, including vegetables, fruits, nuts, pastry, seasonings, organic meals and others. In addition, it provides new medicines, including anticancer medicines, medicines for hepatitis, allergy, rheumatoid arthritis and others. The Company mainly distributes its products mainly within domestic market.
Sector
Food Processing
| 1st Jan change | Capi. | |
|---|---|---|
| -17.23% | 719M | |
| +13.21% | 8.15B | |
| -0.47% | 7.27B | |
| +12.30% | 6.65B | |
| -6.99% | 3.72B | |
| -7.20% | 3.67B | |
| -4.78% | 1.31B | |
| +12.61% | 972M | |
| -43.12% | 866M | |
| -15.02% | 876M |
- Stock Market
- Equities
- 4128 Stock
